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Abstract
In many high technology industries, strategic alliances have become important for improving a
firm’s financial performance by providing knowledge that can be used to develop the capabilities
needed to introduce new products. Therefore, researchers have examined those characteristics of
alliances that can contribute to the performance of high technology companies. There is agreement that
the structure and knowledge flows within alliances can affect a firm’s innovativeness. However, to
date, researchers have studied alliances as individual events or transactions, failing to recognize their
synergistic effects as a coherent portfolio. Viewing alliances as a portfolio of strategic agreements, we
suggest that portfolio characteristics will be associated with a high technology firm’s innovative and
financial performance. Also, we suggest that portfolio characteristics will influence absorptive
capacity. We test these propositions using a sample of 2456 alliances formed by 143 biopharmaceutical
firms. The results indicate that alliance portfolio characteristics and absorptive capacity jointly
influence performance. The implications of these findings for high technology firms are discussed.
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1. Introduction
High technology industries are dynamic and fiercely competitive arenas that require
constant innovation to meet changing customer needs. High technology products are complex
and require the firm to possess knowledge and skills in multiple technological fields and have
to be upgraded constantly in order to meet changes in market conditions and customer
expectations. Therefore, high technology firms can no longer rely exclusively on their
internal skills and knowledge in maintaining innovativeness. These companies access
external sources of knowledge through alliances and harvest this knowledge by creating
innovative products, goods, and services (Arora & Gambardella, 1994; Deeds & Hill, 1996;
Zahra & Bogner, 2000).
Despite the large number of empirical studies on alliances, especially among high
technology companies, few have considered these alliances as a portfolio (e.g., Hagedoorn
& Schakenraad, 1994). Researchers have studied the effect of the number and types of
particular alliances on value creation but, for the most part, have overlooked the potential
synergies or tradeoffs companies experience when they pursue multiple alliances. High
technology companies may enter multiple alliances at the same time, often seeking to achieve
different goals. These goals include gaining access to resources, entering new markets, and
acquiring complementary skills and capabilities. The goals that guide the formation of these
alliances determine the way they are structured and managed which, in turn, influences the
flow of knowledge among alliance participants. The characteristics of the portfolio of
alliances a firm maintains, therefore, can determine the benefits it gains in terms of improved
innovation and financial performance (Nooteboom, 1999). Therefore, it is important to
identify the characteristics of an alliance portfolio that can significantly contribute to a
company’s financial performance.
Knowledge is a key foundation of competitive advantage in science-based industries
(Grant, 1996). Young biotechnology firms may not possess this knowledge internally and,
therefore, have to obtain it from external sources (Zahra, 1996). As firms develop relation-
ships to gain access to external knowledge, their ability to process and transfer the knowledge
gained in one context to another becomes critical (Powell, 1998). A firm’s absorptive
capacity, defined as the ability to value and apply knowledge, is a critical requirement for
learning from external relationships (Cohen & Levinthal, 1990). Absorptive capacity has
been linked to valuable organizational outcomes such as learning and innovation (Kim, 1998;
Mowery, Oxley, & Silverman, 1996). Even in this stream of research, the role of absorptive
capacity in determining a firm’s potential gains from alliances has only been theorized (Koza
& Lewin, 1998), but not adequately tested empirically (Zahra & George, 2000).
This study builds on past research by suggesting that alliance portfolio characteristics will
determine the firm’s absorptive capacity, which, in turn, can influence the performance of a
high technology firm. Absorptive capacity, therefore, is expected to mediate the relationship
between alliance portfolio characteristics and a high technology company’s innovative and
financial performance. To develop this proposition, the study integrates insights from two
complementary theoretical perspectives. The first is the relational perspective of the firm
(Dyer & Singh, 1998; Gulati, 1998, 1999; Koza & Lewin, 1998). This view posits that critical
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resources and value creation activities span the boundary of the firm and may be embedded in
its interfirm relationships (e.g., strategic alliances). The context of these relationships has
important implications for the creation, sharing, and transfer of knowledge. Grounded in trust,
these relationships can enable the high technology firm to acquire new knowledge that can
improve its innovative activities (e.g., new product development). Using the relational
perspective, therefore, we propose that if the high technology firm develops a portfolio of
relationships that portends both stability and access to knowledge sources, then this portfolio
would yield superior financial performance.
The second perspective is the learning theory, which views the value of knowledge as a
key source of competitive advantage (Grant, 1996). It suggests that while the creation of
knowledge is important, the conversion of this knowledge into new products is the foundation
of superior performance (Leonard-Barton, 1995; Moon, 1999; Nonaka & Takeuchi, 1995).
Developing a firm’s absorptive capacity, therefore, is key to gaining a competitive advantage
(Lane & Lubatkin, 1998). Alliances with other firms can provide the firm with adequate
exposure and the experience necessary to develop its absorptive capacity (Cohen &
Levinthal, 1990). The capability to value and exploit external knowledge can be used to
develop products that strengthen the firm’s competitive and financial performance.
Invoking the relational and learning perspectives, this article addresses two issues. First, it
examines alliances as a portfolio of strategic agreements. As noted, the characteristics of the
alliance portfolio would have important implications for innovativeness and financial
performance. To accomplish this objective, the study addresses two characteristics of the
alliance portfolio: structure and knowledge flow. Structure refers to whether an alliance is
completed with a firm at the same level of the value chain (horizontal) or at a different level
(vertical). Alliance structures, whether horizontal or vertical, are associated with varying
degrees of innovativeness (Hagedoorn, 1993; Kotabe & Swan, 1995). Knowledge flows refer
to the direction of knowledge transmission and the sharing that occurs among alliance
partners (Hagedoorn & Schakenraad, 1994). When a portfolio of alliances is considered, this
article suggests that portfolio characteristics, such as structure and knowledge flows, are
likely to be related to performance.
Second, the study also explores the role of absorptive capacity in the context of alliance
portfolio characteristics and firm performance. It suggests that alliance portfolio character-
istics matter with regard to innovative and financial performance and that absorptive capacity
mediates this relationship. By doing so, this study extends past empirical research on alliances
and absorptive capacity, especially in the context of high technology industries. Section 2 of
the paper presents the study’s hypotheses using the relational and learning theoretical
perspectives. This is followed by an empirical test of the hypotheses. Finally, the paper
reviews the results and discusses their implications.
2. Theoretical background and hypotheses
In recent years, there has been unprecedented growth in strategic alliances and various
forms of collaboration in high technology, especially science-based, industries such as
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biotechnology (Baum, Calabrese, & Silverman, 2000; Hagedoorn & Schakenraad, 1994;
Powell, 1998). These alliances can give high technology firms access to different resources,
especially new knowledge (DeCarolis & Deeds, 1999; Powell, Koput, & Smith-Doerr, 1996;
Simonin, 1999; Steensma & Fairbank, 1999) that spurs innovation and new product
development (Deeds & Hill, 1996) that enhance company growth and profitability (Dyer
& Singh, 1998; Gulati, 1998). Given the importance of alliances, researchers have examined
the effect of alliances on the performance of new ventures in the biotechnology industry (e.g.,
DeCarolis & Deeds, 1999; Deeds & Hill, 1996; Liebeskind, Oliver, Zucker, & Brewer, 1996;
Zahra, 1996).
The growing popularity of cooperative research to develop innovative technologies
(Nooteboom, 1999) is evidenced by a positive trend in strategic alliance formation in
biotechnology (Biotechnology Industry Organization (BIO), 1999). These partnerships are
formed based on the partners’ complementarity of assets, either as a set of resources,
capabilities, or knowledge competence (Helfat, 1997; Liebeskind et al., 1996). Alliances
are also formed to develop synergistic relationships through technological complementarity
among partners (Hagedoorn, 1993; Hagedoorn & Schakenraad, 1994). According to March
and Simon (1958), most innovation occurs through borrowing rather than inventing. Since
an organization receives knowledge and information from external sources, the character-
istics of the relationships it maintains with alliance partners can also have a significant
effect on its absorptive capacity as well as on its level of innovation (Dyer & Singh, 1998;
Koza & Lewin, 1998). The relational perspective suggests that a firm’s relationships can
affect its performance. For instance, alliances that require frequent and long-term
interactions can affect a company’s gains quite differently from those characteristics that
are short term or arms-length in nature (Dyer & Singh, 1998; Mowery et al., 1996;
Nooteboom, 1999). Following the relational perspective, the benefits from alliances are
likely to grow if the firm enters and maintains multiple alliances. Learning to organize and
manage multiple alliances also gives the high technology firm the expertise to cultivate
and exploit the knowledge gained from these alliances. Consistent with this proposition, in
Fig. 1, we present a model that relates alliance characteristics, absorptive capacity, and
firm performance.
Absorptive capacity refers to a firm’s ability to value, assimilate, and apply knowledge
received from external sources such as suppliers, customers, competitors, and alliance
partners (Cohen & Levinthal, 1990). Accumulated knowledge that is obtained from
external sources can enhance a firm’s future ability to acquire new knowledge;
prior exposure increases the company’s ability to recognize the importance of new
information (Lindsay & Norman, 1977). A company’s ongoing research and development
activities can play a major role in this regard. R&D investments can enhance the
company’s capabilities to evaluate external knowledge sources (Arora & Gambardella,
1994). Kim (1998) suggests that in order for absorptive capacity to develop, however, a
firm must go beyond evaluating external knowledge and apply this knowledge to
developing new products. Hence, this study captures two components of absorptive
capacity: (a) the ability to evaluate and assimilate knowledge, and (b) the ability to apply
that knowledge.
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2.1. Portfolio analysis and absorptive capacity
Portfolio analysis has been extensively used in the finance literature, especially with regard
to balancing risk and return within a portfolio of stocks (Sharpe, 1963). The basic tenet of the
portfolio approach is ‘‘its concern with economic agents that act under uncertainty’’
(Markowitz, 1952, 1991). The biotechnology industry is an industry characterized by high
uncertainty and hypercompetition (D’Aveni, 1994). Firms enter into alliances with different
motivations that include learning new skills (Baum et al., 2000) or gaining access to
complementary resources (Dyer & Singh, 1998). However, such alliances entail risks and
may be unstable or transitional in nature (Das & Teng, 1996; Inkpen & Beamish, 1997).
Thus, the use of portfolio theory becomes relevant in a context where firms enter into
alliances with the intent of generating economic returns while bearing some risks associated
with these alliances, conceptually similar to a portfolio of stocks. Firms enter multiple
alliance agreements in order to overcome uncertainty and optimize risk, while increasing their
economic returns through the acquisition of necessary resources. Also, information regarding
a firm’s portfolio of alliances is likely to provide greater insight into a firm’s capabilities and
performance than information from a single alliance. Portfolio analysis, as a tool, may
provide better inferences on a firm’s competence due to path dependency and accumulation of
skills and resources (Christensen, 1997; Dosi, 1988). In this study, we begin to empirically
test the characteristics of a firm’s portfolio of alliances and its relationship to innovative and
financial performance.
There are other practical and empirical reasons for our focus on alliance portfolios. As
noted, high technology firms join multiple alliances to gain access to knowledge and skills
across the various phases of their value chain. Examining a portfolio of alliances, rather than
Fig. 1. Relationship between alliance portfolio characteristics and performance.
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individual transactions, takes us one step closer to the locus of value-creating activities.
Studying alliance counts or single alliance announcements, as commonly done in past
research, overlooks the synergistic effects of a firm’s portfolio of alliances. A high technology
firm is likely to capitalize on the multiple knowledge bases by developing alliances along
different points of its value chain. These alliances can be used to expedite the design of new
products. Other alliances can give high technology firms the marketing knowledge needed to
expedite new product development and market introduction. The knowledge gained from
entering multiple alliances can also intensify the frequency of new product development and
increase the radicalness of these products.
The relational and organizational learning perspectives highlight two important character-
istics of the alliance portfolio. The relational perspective suggests that the structure of alliances
has important implications for generating economic rents (Gulati, 1998; Koza & Lewin, 1998).
For example, structural characteristics such as governance, power sharing arrangements,
dependency, or asymmetry may have differing implications for maintenance and appropriation
of economic rents (Kale, Singh, & Perlmutter, 2000; Tsai, 2000). These characteristics usually
reflect the ownership, organization, and management of the alliance itself. The learning
perspective also suggests that alliance characteristics affect the firm’s ability to learn from its
partner (Barkema, Bell, & Pennings, 1996). The way an alliance is structured and managed can
induce trust and reduce opportunism, factors that can encourage the exchange of information
and sharing of knowledge among partners (Kale et al., 2000). Learning from partners is a
complex process that can be influenced by the structural characteristics of the alliance and the
knowledge capability of the partners (Koza & Lewin, 1998; Mowery et al., 1996; Powell,
1998; Simonin, 1999). Some alliances enable partners to observe and learn from each other.
Others, however, may limit the types and frequency of knowledge flows. Thus, the structure of
the alliance is the form of the relationship wherein a partner may provide a resource upstream
or downstream in the value creation process (Hagedoorn & Schakenraad, 1994). Thus,
following the learning perspective, the structure of an alliance has important implications
for the innovative and financial performance of partner firms.
2.1.1. Portfolio structure
Alliance structure embodies horizontal and vertical relationships. Horizontal relationships
are primarily joint product development arrangements. They give the firm new knowledge in
the design, prototyping, testing, development, and introduction of new products. The breadth
of these relationships exposes the high technology firm to multiple and varied sources of
ideas and knowledge, which can fuel innovation. Vertical relationships include outsourcing of
important non-core functions or acquisition of complementary assets needed for innovation.
These vertical relationships can deepen the firm’s knowledge of specific fields, while giving it
access to the resources and assets necessary to create and develop new products. As this
discussion suggests, horizontal and vertical relationships give the firm access to different
types of knowledge that go beyond what the firm already has, thereby broadening a firm’s
potential absorptive capacity.
Specifically, in the biotechnology context, we consider structure of the alliance portfolio
for two main reasons. First, researchers have pointed to the importance of alliance structure to
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stability of the relationship, and the ability to accomplish strategic objectives (Contractor &
Lorange, 1988; Kogut, 1988). The structure of the alliances also indicates the firm’s
motivation to enter and maintain an alliance. Accordingly, horizontal relationships reflect
power sharing and interdependence, whereas vertical relationships entail power asymmetry
(Inkpen & Beamish, 1997). Second, the structure of the alliance affects the firm’s ability to
learn from its partners, and therefore, affects the firm’s ability to evaluate and assimilate
knowledge (Kale et al., 2000). The relational perspective suggests that the structure of an
alliance determines the partners from whom the firm can acquire different skills. These
relationships determine the types of knowledge to be gained and how the firm exploits them.
Therefore, the structure of alliances is an important determinant of a firm’s innovativeness
and performance.
2.1.2. Portfolio knowledge flows
The knowledge flow characteristic of the partnership that influences learning is reflected
by the direction of knowledge transfer and the sharing of that knowledge within an alliance.
Alliances, therefore, can be generative or attractive in nature. Generative alliances usually
involve joint R&D with other firms or research institutions. These alliances are important in
supplying new technology to the firm and, therefore, are useful in shortening the learning
cycle, expediting product development, and reducing R&D costs (Hagedoorn, 1993).
Generative alliances, therefore, require frequent interactions and mutual sharing of knowl-
edge among partners. Following the learning perspective, these interactions can induce
learning by allowing members to observe each other and imitate others’ best practices.
Frequent interactions also induce trust, making partners more willing to exchange ideas and
share sensitive information (Dyer & Singh, 1998). Attractive alliances, on the other hand,
include purchasing and licensing agreements that give the firm access to new knowledge;
with the sharing of knowledge frequently occurring in one direction. This sharing, however,
can help expand the recipient firm’s knowledge base. The learning perspective indicates that a
firm’s exposure to different bases of knowledge can intensify innovativeness (Huber, 1991;
Zahra, Ireland, & Hitt, 2000). Thus, both generative and attractive alliances have the potential
to expand the company’s absorptive capacity. Knowledge flow is especially important in the
biotechnology industry because each type of alliance agreement may provide access to
different types and amounts of knowledge transfer. These variations provide different levels
of learning that ultimately influence the level of absorptive capacity.
By managing its portfolio of attractive and generative partnerships, biotechnology firms
can better acquire and utilize new knowledge and build a competitive advantage. The above
discussion suggests that alliance characteristics designated by structure (horizontal or vertical
alliances) and knowledge flow (generative or attractive) will be related to the firm’s
absorptive capacity (ability to value and apply knowledge). Therefore, we expect a significant
relationship between the firm’s alliance characteristics and its absorptive capacity. Hence, we
posit that:
Hypothesis 1: A firm’s alliance portfolio characteristics will be positively and
significantly related to absorptive capacity. That is:
G. George et al. / Journal of High Technology Management Research 12 (2001) 205–226 211
Hypothesis 1a: The structure of the alliance portfolio will be positively related to
absorptive capacity.
Hypothesis 1b: The knowledge flow characteristics of the alliance portfolio will be
positively related to absorptive capacity.
2.2. Absorptive capacity and performance
The organizational learning perspective highlights the importance of knowledge accumu-
lation and exploitation within organizations (Blackler, 1995; Daft & Weick, 1984; March &
Simon, 1958). Past research on absorptive capacity also highlights the importance of
knowledge in providing the firm with a competitive advantage (Leonard-Barton, 1995;
Van den Bosch, Volberda & de Boer, 1999). Firms that possess superior capabilities to value
and apply this knowledge would, in essence, have superior innovation and performance. In
fact, Cohen and Levinthal (1989) have examined the relationship between absorptive capacity
and learning and developed two dimensions of absorptive capacity that affect innovative
performance within an evolving and uncertain environment. The first dimension centers on
the increased efficiency of a firm in assimilating new knowledge. As a firm assimilates new
knowledge, learning occurs and future knowledge assimilation intensifies and becomes more
efficient. The second dimension is the use of knowledge to exploit technological advance-
ments, which is closely related to the outcomes of innovative behavior. Therefore, the firm
must be able to gain knowledge by scanning the external environment and then transferring
the knowledge throughout the firm to create value (Granstrand & Sjolander, 1990).
Success in science-based industries requires the firm to develop and hone its capabilities
(Bogner, Thomas, & McGee, 1996). Absorptive capacity is considered as a set of capabilities,
such as the ability to value, assimilate, and apply knowledge (Cohen & Levinthal, 1990; Kim,
1998). The underlying assumption is that these capabilities are socially complex routines that
could be a valued organizational resource (Collis, 1994; Hall, 1992). Absorptive capacity can
improve a firm’s performance by ‘‘exploiting existing internal and external firm-specific
competencies to address changing environments’’ (Teece, Pisano, & Shuen, 1997, p. 510).
Past research on absorptive capacity has been grounded in the uncertain and evolving
environment of high technology industries. In these industries, firms need dynamic capa-
bilities to respond to change (Kraatz, 1998; Nicholls-Nixon, 1995). By learning from
experience, a firm is better able to acquire and assimilate knowledge in the future (Cohen
& Levinthal, 1989; Herriot, Levinthal, & March, 1985). Absorptive capacity also encourages
change in a company by promoting innovative behavior as a way to identify and exploit
technological advances (Van den Bosch et al., 1999). Combining knowledge is an important
way to create new products (Zander & Kogut, 1995) and improve financial performance
(Zahra et al., 2000). Consequently, firms that have superior capabilities to acquire and exploit
new knowledge would be expected to have superior innovation and performance. These
observations suggest the following hypothesis:
Hypothesis 2: Absorptive capacity will be positively related to firm performance.
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2.3. Portfolio characteristics and performance
Thus far, we have discussed absorptive capacity as important for a firm’s innovation and
performance. Literature on alliances also suggests that knowledge transcends the boundaries
of the firm and that absorptive capacity could be a function of the relatedness of the partner’s
knowledge base and technological capabilities (Lane & Lubatkin, 1998; Mowery et al.,
1996). A firm’s absorptive capacity is a product of the relationships and access to knowledge
from external sources (Cockburn & Henderson, 1998). Though our preceding discussion
would suggest that alliance characteristics and absorptive capacity may influence firm
performance (Hypotheses 1 and 2, respectively), the benefits of alliances are not likely to
be limited to the development of knowledge capabilities. The relational perspective indicates
that firms gain ‘‘a supernormal profit (that is) jointly generated in an exchange relationship
that cannot be generated by either firm in isolation and can only be contributed by joint
idiosyncratic contributions of the specific alliance partners’’ (Dyer & Singh, 1998, p. 662).
These rents are possible when alliance partners combine, exchange, or invest in assets and
knowledge capabilities (Nooteboom, 1999). Consequently, the benefits of alliance character-
istics are also expected to go beyond improving absorptive capacity.
One potential source of relational rents (i.e., financial performance) is through investments
in specialized assets in conjunction with the assets of the partners (Amit & Schoemaker, 1993;
Carney, 1998). Alliance partners can improve their productivity by making relationship-
specific investments in site, physical assets, and human assets (Williamson, 1985). Site
specificity refers to the successive production stages that are immobile in nature, being located
close to one another, thereby reducing inventory, transportation, and manufacturing coordi-
nation (Dyer, 1996), or improved coordination in R&D and knowledge sharing routines in
high technology industries (Nobel & Birkinshaw, 1998). Physical asset specificity refers to the
investment in specialized physical assets such as capital investments in production and
technology development that are tailored to increase productivity of the exchange among
partners. Investments in specialized physical assets have been found to have positive effects on
a firm’s performance (Holm, Eriksson, & Johanson, 1999). Human asset specificity refers to
developing know-how through repeated interactions between alliance partners. As partners
work together, they increase efficiency by improving communication, knowledge sharing, and
their relative capacity to absorb and utilize knowledge for innovation and product development
(Lane & Lubatkin, 1998; Mowery et al., 1996). As the relationship develops, both alliance
partners begin to invest in relationship-specific assets that yield relational rents. Researchers
have found that investments in such nonrecoverable relational assets can lead to improved
performance of both alliance partners (Carney, 1998; Holm et al., 1999).
Clearly, the characteristics of the alliance portfolio, such as structure and flow, would
influence the development of performance-enhancing capabilities that exceed the development
of a firm’s absorptive capacity. Though alliances are a major source of external knowledge
(Liebeskind et al., 1996; Powell, 1998), they also generate relational rents through, among
others, investments in specialized assets. Therefore, we expect the structure of alliances to
have a greater effect on firm performance than would be explained by absorptive capacity
(Lane & Lubatkin, 1998). Theory development suggests that horizontal alliances are likely to
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give the firm access to multiple types of knowledge. However, vertical alliances may provide
access for biotech firms to commercialize their products or innovations. Vertical alliances may
also increase speed to market as biotech firms frequently ally with larger pharmaceutical firms
to enhance their market presence and capitalize upon the large sales force of these
pharmaceutical firms. With regard to knowledge flow, attractive alliances may enable the
firm to import knowledge from multiple sources, fueling innovation and improving perform-
ance. These observations suggest the study’s third and final hypothesis:
Hypothesis 3: Alliance characteristics will explain a significant variance in firm
performance over and above the variance explained by its absorptive capacity.
Hypothesis 3a: Compared to horizontal alliances, vertical alliances will explain a greater
amount of variance in firm performance over and above the variance explained by its
absorptive capacity.
Hypothesis 3b: Compared to generative alliances, attractive alliances will explain a
significant variance in firm performance over and above the variance explained by its
absorptive capacity.
3. Method
3.1. Sample
To test the study’s hypotheses, data were drawn from the biopharmaceutical industry. In this
study, we consider only the human diagnostics and therapeutics segment, defined as those firms
involved in the R&D of drugs or diagnostics for humans (DeCarolis & Deeds, 1999; Shan,
Walker, & Kogut, 1994; Zahra, 1996). We chose the human diagnostics and therapeutics sector
because firms in this sector have extensively used alliances to gain access to necessary
technology and knowledge. Also, there are significant differences in the degree of innovative-
ness, R&D spending levels, and the drug approval process between the human therapeutics
sector and other sectors such as agricultural or veterinary biotechnology.We believed this sector
to bemost appropriate because it had similarmotivations for firms to enter alliances and reduced
within-industry differences that may confound results and inferences.
Two steps were used to identify firms in the sample. In the first step, a straightforward
classification through SIC codes, yielded 504 firms — 104 firms in Human Diagnostics (SIC
#2835), 96 firms in biological products excluding diagnostics (SIC #2836), and 304 in
pharmaceutical preparations (SIC #2384). This classification included human therapeutics
from biotechnology as well as bulk and specialty drugs. The second step involved eliminating
firms from the pool of 504 based on a firm’s business focus, as provided in The 1997 Guides to
Biotechnology Companies. Only firms involved in gene therapy, human diagnostics, and
therapeutics were included in the analysis. This process yielded 147 publicly traded firmswith a
primary business focus in human gene therapy, diagnostics, and therapeutics. We excluded four
firms that had incomplete alliance information. The final sample consisted of 143 firms.
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3.2. Measures
Data were collected from secondary sources to construct three primary measures: alliance
portfolio characteristics, absorptive capacity, and performance, as explained below.
3.2.1. Alliance portfolio characteristics
Consistent with prior research, an alliance was defined as any cooperative relationship
between firms to develop or commercialize a new product (Deeds & Hill, 1996; Shan et al.,
1994). Data on alliances were obtained from Recombinant Capital, a comprehensive database
on biotechnology firm alliances recommended by the BIO. The database listed all the
alliances that each biotechnology firm had joined since its formation. The database also had
notations on the type (licensing, joint venture, etc.), purpose (business focus), period (number
of years), and size (value in million dollars) of each alliance. The data used in this study
included all alliances (formal agreements) that the firm had entered into until the end of 1995.
Next, the 2456 alliances completed by the 143 firms in the sample were coded as four
submeasures: (a) horizontal alliances, (b) vertical alliances, (c) knowledge generative
alliances, and (d) knowledge attractive alliances, as done previously by Hagedoorn and
Schakenraad (1994) and Kotabe and Swan (1995). Two coders with graduate academic
training in the life sciences were used. Coders agreed on their classification of 96.3% of the
alliances. For the remaining 3.7%, a third coder (with a PhD degree in pharmacy) cast the
deciding vote. Horizontal linkages included joint R&D, patent swaps, technology transfers,
and joint ventures that supplemented a firm’s technology base. Vertical links included
outsourcing and distribution links. Generative linkages involved joint R&D with other firms
or research institutions. Attractive alliances involved purchasing and licensing agreements.
Generative linkages, which supplied new technology to the firm, were useful in shortening
the learning cycle, expediting product development, and reducing R&D costs.
3.2.2. Absorptive capacity
A firm’s absorptive capacity represents its ability to value and assimilate information
(Cohen & Levinthal, 1990). Consistent with this definition, we used two submeasures for
absorptive capacity: R&D spending and the number of patents, as follows.
To gauge the firm’s ability to acquire and value external knowledge, we used R&D
commitment as a key measure. Defined as the absolute value of R&D spending in millions,
R&D commitment has been used in prior studies to gauge absorptive capacity (Cohen &
Levinthal, 1990). Past studies have used R&D spending as a measure of a firm’s input into
innovative activities. In this study, we extend this tradition by using it as a proxy for a firm’s
absorptive capacity. The investments high technology firms make in maintaining a strong
R&D program allow them to attract and keep talented scientists who follow scholarly
developments in the field (Kim, 1997; Zahra, 1996). This allows these researchers to
understand and capture the knowledge created by alliances. Some of this knowledge is tacit
and therefore requires a great deal of expertise. Kim (1997) and Kodama (1995) note the
crucial importance of a firm’s internal R&D in determining its ability to import, comprehend,
and assimilate external knowledge. R&D funds is used also to employ outside experts who
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are knowledgeable in emerging fields. Use of outside experts can compress the absorption
cycle of externally acquired information (Kim, 1997). R&D funds are crucial to supporting
different research projects, a process that enhances learning by doing. This learning enables
the firm to import and use externally created knowledge.
In addition, we used the number of patents in specific fields as a measure of absorptive
capacity (Austin, 1993). Though patents have been used as a measure of a firm’s innovation
(e.g., Deeds & Hill, 1996; Mowery et al., 1996), this study employs patents as a measure of
the firm’s ability to apply or exploit knowledge as suggested by Zahra and George (2000).
For the firm to gain a patent, it has to demonstrate some degree of newness that reflects a
change in the firm’s basic knowledge structure. Patents also record the firm’s evolving or
emerging knowledge and therefore represent a milestone in its progress in discovery and
innovation. Firms usually combine multiple knowledge bases as they pursue product
innovation (Zander & Kogut, 1995). This combinative knowledge is often revealed in the
firm’s own patenting behavior and others’ citations of the firm’s patents (Almeida, 1996).
Patents, therefore, codify some of the learning that has occurred in the high technology firm,
which reveals the firm’s ability to understand, assimilate, and use external knowledge (i.e.,
greater absorptive capacity). Therefore, we used U.S. Patent Class 930 and 935 as indicative
of innovative capability within a specialized field.
3.2.3. Performance
Consistent with Fig. 1, we employed two measures of firm performance. Given that most
biotechnology firms do not make a net profit (BIO, 1999), we used: (a) the number of
products on the market to gauge firm success in developing and introducing new products
(DeCarolis & Deeds, 1999; Shan et al., 1994) and (b) net sales-to-assets to measure a
company’s financial performance that accounted for revenues relative to size (Wu & Ho,
1997). This ratio was especially important given a firm’s need to generate cash flow to
support future R&D.
The data for net sales and R&D spending were collected from Compact Disclosure, all for
1996. The number of products on the market was gathered from The 1997 Guides to
Biotechnology Companies, all for 1996.
3.3. Control variables
The analyses used three control measures: age, industry sector, and venture origin.
Organizational age has been related to firm survival and mortality rates (Hannan & Freeman,
1984; Levinthal, 1991). Organizational age, taken from The 1997 Guides to Biotechnology
Companies was measured in years from the date of incorporation, as done in prior research
(Cooper, Woo, & Dunkelberg, 1989; Deeds & Hill, 1996; Zahra, 1996; Zahra et al., 2000).
Next, industry sector was used to control for within-industry differences. Therefore, we
dummy-coded the firm’s industry sector by their SIC classification. Finally, we used venture
origin to control for corporate or independent ventures. Researchers suggest that significant
differences exist between independent and corporate biotech ventures due to differences in
their resource base and capabilities (Zahra & George, 1999).
G. George et al. / Journal of High Technology Management Research 12 (2001) 205–226216
T
ab
le
1
D
es
cr
ip
ti
v
e
st
at
is
ti
cs
an
d
co
rr
el
at
io
n
s
(N
=
1
4
3
)
V
ar
ia
b
le
s
M
ea
n
(S
.D
.)
1
2
3
4
5
6
7
8
9
1
0
1
1
1
2
(1
)
A
g
e
9
.6
5
(3
.2
3
)
1
(2
)
V
en
tu
re
o
ri
g
in
0
.2
0
(0
.4
0
4
)
.0
3
1
(3
)
P
h
ar
m
a
se
ct
o
r
(2
8
3
4
)
0
.3
1
(0
.4
6
6
)

.1
2
.2
8
*
*
1
(4
)
D
ia
g
n
o
st
ic
s
se
ct
o
r
(2
8
3
5
)
0
.1
5
(0
.3
6
2
)
.0
6

.0
2

.2
9
*
*
1
(5
)
A
b
il
it
y
to
v
al
u
e
k
n
o
w
le
d
g
e
(R
&
D
sp
en
d
in
g
)
1
0
6
.2
1
(3
0
6
.1
8
)
.0
5
.5
7
*
*
.4
2
*
*

.1
4
1
(6
)
A
b
il
it
y
to
ap
p
ly
k
n
o
w
le
d
g
e
(p
at
en
ts
)
3
.3
6
(1
0
.7
6
)
.3
5
*
*
.1
5
y
.1
5
y

.0
9
.4
1
*
*
1
(7
)
H
o
ri
zo
n
ta
l
al
li
an
ce
s
6
.1
5
(7
.5
5
)
.1
2
.4
7
*
*
.3
7
*
*

.1
3
.7
4
*
*
.5
8
*
*
1
(8
)
V
er
ti
ca
l
al
li
an
ce
s
1
0
.9
8
(1
3
.9
6
)
.2
4
*
*
.5
2
*
*
.3
3
*
*

.1
3
.7
5
*
*
.4
3
*
*
.7
5
*
*
1
(9
)
G
en
er
at
iv
e
al
li
an
ce
s
6
.0
2
(5
.7
6
)
.2
2
*
*
.4
1
*
*
.2
8
*
*

.1
0
.6
2
*
*
.5
7
*
*
.9
0
*
*
.7
6
*
*
1
(1
0
)
A
tt
ra
ct
iv
e
al
li
an
ce
s
6
.4
0
(7
.3
6
)
.1
5
y
.4
8
*
*
.3
4
*
*

.1
3
.7
4
*
*
.5
3
*
*
.7
7
*
*
.8
6
*
*
.7
3
*
*
1
(1
1
)
P
ro
d
u
ct
s
o
n
m
ar
k
et
1
.1
5
(2
.2
2
)
.3
5
*
*
.2
7
*
*

.0
5
.0
4
.5
6
*
*
.3
1
*
*
.0
8
.4
4
*
*
.1
3
.2
6
*
*
1
(1
2
)
N
et
sa
le
s/
as
se
ts
0
.3
3
(0
.3
9
)
.2
3
*
*
.2
2
*
.1
8
*
.1
1
.4
1
*
*
.1
9
*
.2
7
*
*
.3
7
*
*
.2
6
*
*
.2
6
*
*
.4
1
*
*
1
*
P
<
.0
5
.
*
*
P
<
.0
1
.
y
P
<
.1
0
.
G. George et al. / Journal of High Technology Management Research 12 (2001) 205–226 217
4. Results
Table 1 presents the summary statistics and correlations among the variables. As Table 1
indicates, most of the study’s predictions are supported by the significant correlations
observed among the variables with many of the correlations being quite large (P < .001).
Next, to examine the relative effects of portfolio characteristics on performance, we used
hierarchical multiple regression analysis. Therefore, we entered the control variable (company
age, venture origin, and industry sector) in Step 1. Age, venture origin, and industry sector
controls were statistically significant in some of the regression equations, thus supporting
their use as control measures.
To test Hypothesis 1 (Hypotheses 1a and 1b), we introduced portfolio characteristics as
predictors of the absorptive capacity measures in Step 2 (Table 2). To test Hypothesis 2, we
introduced absorptive capacity as a predictor of performance in Step 2 (Table 3). Sub-
sequently, to test Hypothesis 3 (Hypotheses 3a and 3b), we introduced the portfolio
characteristics in Step 3 of the hierarchical regression (Table 3). Finally, to determine the
unique amount of variance explained by each block of variables, we examined the increase in
adjusted R2.
Hypothesis 1 (Hypotheses 1a and 1b), which suggested a significant association between
alliance portfolio characteristics and absorptive capacity, was supported because three of the
four portfolio characteristics were related to the two measures of absorptive capacity.
Specifically, as reported in Table 2, horizontal (Hypothesis 1a) and knowledge attractive
alliances (Hypothesis 1b) had positive beta coefficients (b= 0.30 and .55, P< .10 and P < .01,
Table 2
Portfolio characteristics as predictor of absorptive capacity
Independent
Ability to value knowledge
(R&D spending)
Ability to apply
knowledge (Patents)
Step variables b Adj. R2 D Adj. R2 b Adj. R2 D Adj. R2
1 Constant  56.81 .38***  11.39 .14***
Venture origin 0.16**  0.12
Pharma
sector (2834)
0.08  0.02
Diagnostics
sector (2835)
0.00  0.03
Age  0.04 0.29** *
2 Horizontal alliances 0.60*** .72*** .34 0.30y .47*** .33
Vertical alliances 0.34***  0.43* *
Generative alliances  0.42*** 0.21
Attractive alliances 0.23 * 0.55** *
Standardized beta values are reported for the final step.
Adjusted R2 are reported for each step. N= 143.
* P< .05.
** P < .01.
*** P < .001.
y P < .10.
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respectively), whereas vertical alliances (Hypothesis 1a) had a negative coefficient
(b = 0.43, P < .01) when the ability to apply knowledge (patents) was the dependent
variable. Generative alliances were not related to patent output. Together, the portfolio
characteristics accounted for a change in adjusted R2 of .33 for the ability to apply
knowledge. When the dependent variable was the firm’s ability to value externally generated
knowledge (R&D commitment), horizontal and vertical alliances (Hypothesis 1a) had
positive coefficients (b = 0.60 and .34, respectively, P< .001) whereas generative alliances
(Hypothesis 1b) had a negative coefficient (b= 0.42, P< .001) and attractive alliance was a
significant predictor of R&D spending (b = 0.23, P < .05). Together, the portfolio character-
istics accounted for a change in adjusted R2 of .34 of a firm’s R&D commitment.
Hypothesis 2, on the association of absorptive capacity and firm performance, received
partial support (Table 3). Of the two absorptive capacity measures, only the ability to value
knowledge (R&D investment) was a significant predictor of products on the market (b= 0.45,
P < .001) and net sales/assets (b= 0.36, P < .05).
As predicted, Hypothesis 3 was supported. Alliance portfolio characteristics explained
additional statistically significant variance in the products on the market (DR2=.05) and a
marginal but significant difference in net sales/assets (DR2=.01) over and above the
predictive power of absorptive capacity and the control variables (age, venture origin, and
industry sector).
Of the controls used, venture origin was a significant predictor of R&D spending, which
was consistent with other studies that suggest that corporate ventures have additional
Table 3
Portfolio characteristics and absorptive capacity as predictors of performance
Independent Products on market Net sales/assets
Step variables b Adj. R2 D Adj. R2 b Adj. R2 D Adj. R2
1 Constant 0.08 .16*** 0.05 .15***
Venture origin 0.16  0.01
Pharma sector (2834)  0.09 0.14
Diagnostics sector (2835) 0.08 0.22**
Age 0.19 * 0.16y
2 Ability to value
knowledge (R&D spending)
0.45*** .40*** .24 0.36 * .22*** .07
Ability to apply
knowledge (patents)
0.04 0.06
3 Horizontal alliances 0.25 .45*** .05  0.07 .23*** .01
Vertical alliances 0.65** 0.39 *
Generative alliances  0.57**  0.06
Attractive alliances  0.37 *  0.28
Standardized beta values are reported for the final step.
Adjusted R2 are reported for each step. N= 143.
* P< .05.
** P < .01.
*** P < .001.
y P < .10.
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resources at their disposal and hence have higher R&D spending (e.g., Zahra, 1996; Zahra &
George, 1999). Also, age was a significant predictor of performance as well as absorptive
capacity. This result underscored the importance of time to develop a firm’s absorptive
capacity and leveraging it towards value creation.
5. Discussion and implications
High technology industries are important for the growth of the national economy. Given
the fierce competition that prevails in these industries, researchers have attempted to
identify the factors that determine success and failure of high technology firms (Carroll,
1993; Rumelt, Schendel, & Teece, 1991). There is agreement that constant innovation is the
key to gaining and maintaining competitive advantage in these industries. However,
innovation hinges on the ability of the high technology firm to assimilate and exploit
different types of knowledge. In younger high technology industries such as biotechnology,
very few firms have the resources (especially knowledge) needed to sustain innovation.
Strategic alliances are an important means by which high technology firms can achieve this
objective. Today, many high technology firms are members of multiple alliances, aiming to
achieve multiple goals.
This article contributes to the literature by examining and providing support for the
importance of alliance portfolio characteristics for firm performance. Both the relational and
learning perspectives highlight the importance of alliance structure for value creation and this
paper provides support for the key propositions of these two perspectives. The article also
extends the literature by exploring and addressing the differential relationships between
portfolio characteristics and performance. These issues have been discussed in the literature
but have not been documented empirically. Another contribution of this study is highlighting
the intermediary role of absorptive capacity as a source of influence on firm performance.
Even though the role of absorptive capacity in creating value has been the subject of interest
in the literature, it has not been carefully documented in empirical research (Zahra & George,
2000). These two contributions should be viewed in the context of inadequate empirical
testing in prior studies of the role of absorptive capacity within research on strategic alliances.
Simonin (1999, p. 596) notes that ‘‘unlike the profusion of conceptual work, there has only
been limited empirical work on the role of knowledge in strategic alliances that goes beyond
small-sample, in-depth studies of a few organizations.’’ This study begins to address this gap
in the literature by examining 2456 alliances of 143 biotechnology firms.
The results have three important implications. First, consistent with the relational and
learning perspectives, the results support the importance of studying alliance characteristics
(i.e., how information is transferred between firms) and their potential affect on value creation
in high technology firms. This finding has theoretical and practical implications. It reinforces
the importance of considering alliances as a bundle of capabilities, which is an issue that
needs greater attention in future empirical research. The findings indicate that future
researchers should explore the way alliances are structured in order to determine if structure
impacts potential gains that the firm can achieve. Counting alliances, as widely done in prior
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research, may not fully capture the gains realized from these alliances. Researchers need to
probe their structure and knowledge flow patterns as well, as suggested by proponents of the
relational and organizational learning perspectives. Indeed, as evident from the theory
section, the proponents for the relational and learning perspectives converge in their views
about the role of alliances in creating value in high technology firms.
The practical implication of our results is unique in that alliances can be viewed as a
portfolio. Similar to a portfolio of stocks, where investors hedge risk through diversification
or maximize risk to maximize return, managers may view alliances as capability-enhancing or
as a means for acquiring access to resources. For example, managers can opt for vertical
rather than horizontal alliances to maximize the probability of bringing a product to market.
Managers might develop this portfolio in a way that reduces the overall risk of organizational
failure. Alternatively, executives may attempt to balance the business vs. the technological
risks associated with the use of a diverse set of alliances.
Second, the results highlight the differential effect of the portfolio characteristics on
performance. As the results indicate, the beta coefficients for different portfolio characteristics
are not in the same direction. For example, horizontal alliances are positively related to
patents (innovative capability), whereas vertical alliances are negatively related to patents.
Also, vertical alliances are positively related to performance, whereas horizontal alliances are
not significant predictors of company performance. With these results in mind, future
researchers should study portfolio characteristics in different industries and organizational
cohorts. In the current biotechnology sample, it is plausible that in order to commercialize
their products, biotechnology firms establish ties with larger pharmaceutical firms who have a
dedicated marketing and sales network. Smaller firms that do not have the financial resources
to establish their own sales team may opt to enter such vertical alliances with pharmaceutical
firms. Though our sample includes independent and well-known biotechnology firms (e.g.,
Amgen and Biogen), these firms may opt to outsource their marketing efforts in order to
remain with their core competence of drug research. We do not know if the mix of alliance
portfolio characteristics or the effect of these characteristics on company performance will
persist in other high technology industries or in more established firms. Here too, we believe
it is beneficial for future scholars to use the relational and learning perspectives in examining
the effect of different dimensions of alliance characteristics.
The third implication of our results centers on the role of absorptive capacity. Following
Cohen and Levinthal’s (1989, 1990) work on this construct, absorptive capacity has been
extensively invoked conceptually (Kim, 1998; Koza & Lewin, 1998; Nicholls-Nixon, 1995)
but with little empirical verification (e.g., Lane & Lubatkin, 1998). Thus, the role of the
absorptive capacity construct has not been verified across different organizational contexts.
Our results highlight the importance of this construct for firm performance and its role within
the alliance portfolio characteristic framework. They also suggest that alliance portfolio
characteristics are related to absorptive capacity and, in turn, organizational performance. We
can explain about 45% of the variance in products on the market and 23% of the variance in
net sales/assets when we combine the predictive power of the two constructs. Absorptive
capacity enables the firm to transform knowledge gained from outside to products, goods, and
services. Future researchers may want to further explore the intricacies of differential
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relationships between alliance portfolio characteristics and the firm’s absorptive capacity,
using the relational and learning perspectives discussed in this paper.
5.1. Limitations
Despite the fact that our results are encouraging, they should be interpreted with
caution because of the study’s limitations. To consider the alliances that a firm has forged
since its inception also raises some difficult conceptual and measurement issues. Similar to
a stock portfolio where risk and return measures are likely to exhibit high correlation,
some of the measures of structure and knowledge flow exhibit high correlations. Such
correlations may also be indicative of multicollinearity issues that need to be addressed in
future research designs. Also, the study’s cross-sectional design makes it difficult to
establish causal relationships among the variables. Due to path dependence in a firm’s
evolution of capabilities, future research should consider alliance characteristics using
time-series models that can better clarify the relationships between alliance characteristics
and performance as well as control for past innovative and financial performance. Such
time-series analysis may also allow the use of multiple control measures for each time
frame. For instance, firm size, executive compensation, and products commercialized in
any given year could be used as control measures. Also, given the dynamic evolution of
the biotechnology industry, the results might capture relationships among variables of
interest at only one point in time. Moreover, while there are several important benefits for
single industry studies, the fact that this research was conducted in the biotechnology
industry might limit the generalizability of the findings. Finally, the current results might
reflect the nature of the measures used, especially those related to absorptive capacity.
Future studies might benefit from exploring other indicators of absorptive capacity;
indeed, the use of alternative measures would only help to establish the robustness of
the current findings.
5.2. Future research directions
The results have important implications for future research into high technology firms.
The notion of considering alliances as a portfolio that can be managed deserves further
study. How do firms use their portfolio to gain access to different types of knowledge?
How do firms balance risks in their alliance portfolio? This study combines two theoretical
perspectives and empirically tests their position that to this point has received conceptual
attention but inadequate empirical scrutiny. The relational perspective of the firm posits
that managing relationships effectively would yield economic rents (Dyer & Singh, 1998).
Our findings support this proposition and improve our understanding of a firm’s absorptive
capacity. The organizational learning literature emphasizes the importance of a firm’s
ability to assimilate, value, and leverage information from external sources to derive a
competitive advantage. Future researchers should seek to further validate the propositions
of these two perspectives in different segments of the biotechnology industry or other high
technology industries.
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In high technology industries, such as biotechnology, managing a portfolio of relationships
may be crucial to firm survival and growth. The empirical support for the importance of
portfolio characteristics as a means of value creation is encouraging and worthy of attention in
future research on managing high technology firms. Understanding the effect of alliances on a
firm’s performance is a central issue in the literature. Alliances contribute to a firm’s perform-
ance directly by creating relational rents. Alliance characteristics also contribute significantly to
the firm’s absorptive capacity that, in turn, influences its financial and innovative performance.
We hope that future researchers will draw upon the learning and relational perspectives as they
examine the processes by which high technology companies build their absorptive capacity and
effectively harness it in pursuit of value-creating innovations.
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